212.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$213.46
Aprire:
$213.62
Volume 24 ore:
1.32M
Relative Volume:
0.60
Capitalizzazione di mercato:
$50.48B
Reddito:
$234.31B
Utile/perdita netta:
$1.61B
Rapporto P/E:
32.07
EPS:
6.6243
Flusso di cassa netto:
$4.45B
1 W Prestazione:
+5.64%
1M Prestazione:
+7.36%
6M Prestazione:
+31.87%
1 anno Prestazione:
+67.24%
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Confronta CAH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health Inc
|
212.45 | 50.72B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
840.46 | 104.19B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
354.85 | 68.94B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
79.98 | 9.19B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5902 | 840.28M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health, Inc. (CAH) shares gain favor as Citi turns bullish on specialist assets - MSN
Cardinal Health Upgraded to Buy by Citi, Price Target Raised to $244 - Intellectia AI
Cardinal Health, Inc. (CAH) Shares Gain Favor as Citi Turns Bullish on Specialist Assets - Yahoo Finance
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue? - sharewise.com
Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue - Yahoo Finance
Procyon Advisors LLC Makes New Investment in Cardinal Health, Inc. $CAH - MarketBeat
Nordea Investment Management AB Increases Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. $CAH Stake Reduced by Cairn Investment Group Inc. - MarketBeat
Dividend Stock Analysis: Cardinal Health, Inc. - Longbridge
Lobbying Update: $60,000 of CARDINAL HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Buyback Watch: What is the earnings history of Cardinal Health IncGlobal Markets & Weekly High Return Stock Forecasts - baoquankhu1.vn
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report? - Finviz
Cardinal Health (NYSE:CAH) Sets New 1-Year High on Analyst Upgrade - MarketBeat
Wells Fargo & Company Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price - MarketBeat
Wells Fargo Raises Price Target for Cardinal Health (CAH) to $23 - GuruFocus
Cardinal Health stock reaches all-time high at $214.93 By Investing.com - Investing.com Canada
Cardinal Health (NYSE:CAH) S&P 500 ETF Healthcare Infrastructure - Kalkine Media
Cardinal Health boosts profit forecast to $10/share, expands Publix deal - The Business Journals
Cardinal Health introduces ContinuCare™ Pathway; announces relationship with Publix - WebWire
10 Biggest Healthcare Companies - Investopedia
Cardinal Health raises 2026 profit forecast - WHTC
Leerink Partners Adjusts Price Target on Cardinal Health to $240 From $230, Maintains Outperform Rating - marketscreener.com
Baird Adjusts Price Target on Cardinal Health to $250 From $232, Maintains Outperform Rating - marketscreener.com
GRIMES & Co WEALTH MANAGEMENT LLC Purchases New Position in Cardinal Health, Inc. $CAH - MarketBeat
Why the Market Dipped But Cardinal Health (CAH) Gained Today - Yahoo Finance
Does Expanded Rapiblyk Distribution Hint at a Deeper Shift in Cardinal Health’s (CAH) Specialty Strategy? - Sahm
Key facts: Cardinal Health raises earnings outlook; completes drug deals; launches diabetes program - TradingView — Track All Markets
Cardinal Health Stock Jumps on Guidance Raise. Why 2026 Will Be a Good Year. - Barron's
Cardinal Health Inc (CAH) Stock Price Up 3.95% on Jan 13 - GuruFocus
Cardinal Health raises fiscal 2026 earnings outlook to at least $10 per share - Investing.com Canada
Cardinal Health (CAH) Raises FY26 Earnings Outlook, Shares Climb - GuruFocus
Why Is Cardinal Health Stock Gaining Tuesday?Cardinal Health (NYSE:CAH) - Benzinga
Cardinal Health (NYSE:CAH) Issues FY 2026 Earnings Guidance - MarketBeat
Cardinal Health (CAH) Boosts Earnings Expectations for 2026 - GuruFocus
Liberty One Investment Management LLC Acquires 217,826 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health introduces ContinuCare Pathway alongside Publix partnership - Drug Store News
Cardinal Health beats with raised FY26 outlook (CAH:NYSE) - Seeking Alpha
Cardinal Health raises 2026 profit forecast on specialty drug demand - Reuters
Cardinal Health (CAH) Updates Fiscal Year 2026 Earnings Outlook - GuruFocus
Cardinal Health gains after raising 2026 profit forecast - TradingView — Track All Markets
(CAH) Cardinal Health Expects Fiscal 2026 Adjusted EPS At Least $10, vs. FactSet Est of $9.86 - marketscreener.com
Cardinal Health Inc Updates Fiscal 2026 Outlook and Strategic Initiatives - TradingView — Track All Markets
Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation - Barchart.com
Tema Etfs LLC Makes New Investment in Cardinal Health, Inc. $CAH - MarketBeat
SG Americas Securities LLC Reduces Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Sterilization Services MarketGlobal Forecast 2025-2032: - GlobeNewswire
CPC Advisors LLC Makes New Investment in Cardinal Health, Inc. $CAH - MarketBeat
Should Value Investors Buy Cardinal Health (CAH) Stock? - sharewise.com
Will Analyst Upgrades and Specialty Focus Change Cardinal Health's (CAH) Healthcare Supply Chain Narrative? - Yahoo Finance
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds - The Globe and Mail
Jim Cramer says “Cardinal is really the monster” among drug distributors - MSN
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):